Evidence map›Paper›PMID 33556239›Full record

ArticleACS nano2021

Spatial Regulation of T-Cell Signaling by Programmed Death-Ligand 1 on Wireframe DNA Origami Flat Sheets.

Trixy Fang, Jonatan Alvelid, Joel Spratt, Elena Ambrosetti, Ilaria Testa, Ana I Teixeira

Open access · hybridAbstract read
In one paragraph

Article in ACS nano, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. Analyzing Molecular Determinants of Nanodrugs' Cytotoxic Effects.International journal of molecular sciences · 2025
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Fluidic Interface for Surface-based DNA Origami Studies.ACS applied materials & interfaces · 2024
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Trixy FangDepartment of Medical Biochemistry and Biophysics, Karolinska Institute, 171 65 Stockholm, Sweden.
Jonatan AlvelidDepartment of Applied Physics and Science for Life Laboratory, KTH Royal Institute of Technology, 100 44 Stockholm, Sweden.
Joel SprattDepartment of Medical Biochemistry and Biophysics, Karolinska Institute, 171 65 Stockholm, Sweden.ORCID 0000-0002-8720-5011
Elena AmbrosettiDepartment of Medical Biochemistry and Biophysics, Karolinska Institute, 171 65 Stockholm, Sweden.
Ilaria TestaDepartment of Applied Physics and Science for Life Laboratory, KTH Royal Institute of Technology, 100 44 Stockholm, Sweden.
Ana I TeixeiraDepartment of Medical Biochemistry and Biophysics, Karolinska Institute, 171 65 Stockholm, Sweden.ORCID 0000-0001-8169-8815
Karolinska Institutet · SEScience for Life Laboratory · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Programmed Death-1 (PD-1) is a coinhibitory receptor expressed on activated T cells that suppresses T-cell signaling and effector functions. It has been previously shown that binding to its ligand PD-L1 induces a spatial reorganization of PD-1 receptors into microclusters on the cell membrane. However, the roles of the spatial organization of PD-L1 on PD-1 clustering and T-cell signaling have not been elucidated. Here, we used DNA origami flat sheets to display PD-L1 ligands at defined nanoscale distances and investigated their ability to inhibit T-cell activation

Indexed as

B7-H1 AntigenT-LymphocytesDNAProgrammed Cell Death 1 ReceptorSignal TransductionB7-H1 AntigenDNAProgrammed Cell Death 1 Receptorcancer immunotherapyDNA nanotechnologyDNA origaminanoscale spatial distributionPD-1 receptor

Identifiers

PMID33556239
PMCPMC7905882
OpenAlexW3128170357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.